MARKET

CELC

CELC

Celcuity
NASDAQ

Real-time Quotes | Nasdaq Last Sale

27.14
+0.30
+1.12%
Closed 16:00 05/07 EDT
OPEN
26.87
PREV CLOSE
26.84
HIGH
27.95
LOW
26.59
VOLUME
45.24K
TURNOVER
--
52 WEEK HIGH
30.42
52 WEEK LOW
4.795
MARKET CAP
333.49M
P/E (TTM)
-29.4137
1D
5D
1M
3M
1Y
5Y
Stocks That Hit 52-Week Highs On Tuesday
    Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs.
Benzinga · 4d ago
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28)
Benzinga · 04/29 12:15
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27)
Benzinga · 04/28 11:26
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26)
Benzinga · 04/27 11:41
Celcuity Inc. Schedules Release of First Quarter 2021 Financial Results and Webcast
April 26, 2021 (ACCESSWIRE via COMTEX) -- MINNEAPOLIS, MN / ACCESSWIRE / April 26, 2021 / Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company...
ACCESSWIRE · 04/26 21:00
Celcuity, Inc. (CELC) is on the Move, Here's Why the Trend Could be Sustainable
Celcuity, Inc. (CELC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Zacks · 04/23 13:35
Celcuity's (CELC) Shares March Higher, Can It Continue?
Zacks.com · 04/15 12:58
The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 13)
Benzinga · 04/14 11:51
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CELC. Analyze the recent business situations of Celcuity through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CELC stock price target is 30.00 with a high estimate of 30.00 and a low estimate of 30.00.
EPS
Institutional Holdings
Institutions: 56
Institutional Holdings: 2.07M
% Owned: 16.87%
Shares Outstanding: 12.29M
TypeInstitutionsShares
Increased
5
13.26K
New
2
3.78K
Decreased
9
20.63K
Sold Out
4
3.31K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
About CELC
Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the targeted therapy that best treats it. CELx platform provides traditional molecular diagnostics, which provides a snapshot of the genetic mutations present in a patient’s tumor because they analyze dead cells. Using dead cells prevents molecular diagnostics from analyzing in real-time the dynamic cellular activities, known as cell signaling, that regulate cell proliferation or survival.

Webull offers kinds of Celcuity Inc stock information, including NASDAQ:CELC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CELC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CELC stock methods without spending real money on the virtual paper trading platform.